Müller K, Huang H S, Wiegrebe W
Institut für Pharmazie, Universität Regensburg, Germany.
J Med Chem. 1996 Aug 2;39(16):3132-8. doi: 10.1021/jm960259l.
The synthesis of a series of 1,8-dihydroxy-9(10H)-anthracenones bearing sulfur-linked substituents in the 10-position is described. These compounds were evaluated for their ability to inhibit the growth of the human keratinocyte cell line HaCaT and the 5- and 12-lipoxygenase enzymes in bovine polymorphonuclear leukocytes and mouse epidermal homogenate, respectively. In addition, the following redox properties of the compounds were determined: reactivity against 2,2-diphenyl-1-picrylhydrazyl, generation of hydroxyl radicals as measured by deoxyribose degradation, and inhibition of lipid peroxidation in model membranes. Compounds 4e and 4h of this series compare favorably in the cellular assays with the antipsoriatic anthralin. They have the combined inhibitory action against leukotriene B4 and 12(S)-HETE formation and are highly potent antiproliferative agents against keratinocyte growth. In contrast to anthralin, 4h, 1,8-dihydroxy-10-[(4-hydroxyphenyl)thio]-9(10H)-anthracenone, is not cytotoxic as documented by the LDH activity released from cytoplasm of keratinocytes and does not enhance lipid peroxidation in model membranes.
本文描述了一系列在10位带有硫连接取代基的1,8 - 二羟基-9(10H)-蒽酮的合成。分别评估了这些化合物抑制人角质形成细胞系HaCaT生长以及牛多形核白细胞和小鼠表皮匀浆中5 - 和12 - 脂氧合酶的能力。此外,还测定了这些化合物的以下氧化还原性质:对2,2 - 二苯基-1 - 苦基肼的反应性、通过脱氧核糖降解测定的羟基自由基生成以及对模型膜中脂质过氧化的抑制作用。该系列化合物4e和4h在细胞试验中与抗银屑病药物蒽林相比具有优势。它们对白三烯B4和12(S)-HETE的形成具有联合抑制作用,并且是针对角质形成细胞生长的高效抗增殖剂。与蒽林不同,4h,即1,8 - 二羟基-10 - [(4 - 羟基苯基)硫代]-9(10H)-蒽酮,根据角质形成细胞胞质中释放的乳酸脱氢酶活性证明没有细胞毒性,并且在模型膜中不会增强脂质过氧化。